The goal of this clinical trial is to find out whether a phenotype-based pain management approach can reduce chronic pain in adults (18 years and older) who have completed curative treatment for head and neck cancer and continue to experience chronic post-treatment pain. The main questions it aims to answer are: * Does a phenotype-based pain management approach reduce participants' average pain by at least 75% after one month of treatment? * Is the treatment safe, with 10% or fewer participants stopping treatment because of side effects? Participants will: * Attend three study visits over
For full eligibility, visit ClinicalTrials.gov.
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Head and Neck Cancer Trials on Trialify →